| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/09273948.2010.498657 |
| P953 | full work available at URL | http://www.tandfonline.com/doi/pdf/10.3109/09273948.2010.498657 |
| P698 | PubMed publication ID | 20735287 |
| P2093 | author name string | Michael Stern | |
| Canan Asli Utine | |||
| Esen K. Akpek | |||
| P2860 | cites work | Investigative Ophthalmology Visual Science | Q6060707 |
| Topical cyclosporine in the management of shield ulcers | Q79907134 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| Uses and safety profile of ciclosporin in ophthalmology | Q80435644 | ||
| Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease | Q81551290 | ||
| Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis | Q82140417 | ||
| Prevention and treatment of corneal graft rejection: current practice patterns (2004) | Q83190251 | ||
| A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis | Q83830053 | ||
| Annals of ophthalmology | Q27709038 | ||
| Revue internationale du trachome et de pathologie oculaire tropicale et subtropicale et de sante publique : organe de la Ligue contre le trachome avec la collaboration de l'International Organization against Trachoma et des organisation... | Q27713160 | ||
| Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology | Q27713630 | ||
| Biological effects of cyclosporin A: A new antilymphocytic agent | Q28299720 | ||
| Confocal microscopic findings in a case of delayed-onset bilateral diffuse lamellar keratitis after laser in situ keratomileusis | Q31101689 | ||
| Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis | Q33246357 | ||
| Vernal keratoconjunctivitis | Q33640914 | ||
| Vernal keratoconjunctivitis in an Israeli group of patients and its treatment with sodium cromoglycate | Q33641705 | ||
| Androgens and dry eye in Sjögren's syndrome | Q33692681 | ||
| Molecular and cellular aspects of allergic conjunctivitis. | Q33789948 | ||
| Ligneous conjunctivitis: a clinicopathologic study of 3 cases | Q33837879 | ||
| Ligneous conjunctivitis | Q33967011 | ||
| Changing concepts in the diagnosis and management of blepharitis | Q34048206 | ||
| High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen | Q34076208 | ||
| Superficial punctate keratitis | Q34295952 | ||
| Cyclosporin A in patients receiving renal allografts from cadaver donors | Q34347891 | ||
| The pathology of dry eye. | Q34391929 | ||
| Dry eye after haematopoietic stem cell transplantation | Q35307825 | ||
| Randomised controlled trial of corticosteroid regimens in endothelial corneal allograft rejection | Q35308369 | ||
| Bilateral keratoconjunctivitis associated with lichen planus | Q35618900 | ||
| Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation | Q35619625 | ||
| An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis | Q71064375 | ||
| Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome | Q72418731 | ||
| Immunological analysis and treatment of Mooren's ulcer with cyclosporin A applied topically | Q72658434 | ||
| Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sjögren's syndrome | Q72658445 | ||
| Topical cyclosporin A in the treatment of anterior segment inflammatory disease | Q72769887 | ||
| Pilot trial of cyclosporine 1% ophthalmic ointment in the treatment of keratoconjunctivitis sicca | Q72852578 | ||
| [Local cyclosporin A therapy in Thygeson superficial punctate keratitis--a pilot study] | Q73099427 | ||
| Epidemiological study of 134 subjects with allergic conjunctivitis | Q73138162 | ||
| Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes | Q73180482 | ||
| Use of topical cyclosporin for conjunctival manifestations of actinic prurigo | Q73314238 | ||
| Periductal Area as the Primary Site for T-Cell Activation in Lacrimal Gland Chronic Graft-Versus-Host Disease | Q73316505 | ||
| A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis | Q73483860 | ||
| Lichen planus and cicatrizing conjunctivitis: characterization of five cases | Q73727461 | ||
| Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis | Q73903283 | ||
| T-cell cytokines in chronic allergic eye disease | Q74075312 | ||
| Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion | Q74120740 | ||
| Superior limbic keratoconjunctivitis: multifactorial mechanical pathogenesis | Q74300837 | ||
| Effect of topical cyclosporin A on Thygeson's superficial punctate keratitis | Q74460127 | ||
| A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis | Q77352442 | ||
| Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs | Q77387249 | ||
| Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine | Q77729873 | ||
| Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study | Q77763051 | ||
| Topical cyclosporin A in Thygeson's superficial punctate keratitis | Q78165480 | ||
| Ag-Specific Recognition, Activation, and Effector Function of T Cells in the Conjunctiva with Experimental Immune-Mediated Blepharoconjunctivitis | Q79080254 | ||
| Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood | Q79171943 | ||
| Ophthalmic cyclosporine use in ocular GVHD | Q79320052 | ||
| Thygeson's superficial punctate keratitis: ten years' experience | Q35623513 | ||
| The role of the lacrimal functional unit in the pathophysiology of dry eye. | Q35755146 | ||
| Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. | Q35761720 | ||
| Changes in the tear film and ocular surface from dry eye syndrome | Q35818760 | ||
| Immunomodulatory therapy in ophthalmology - is there a place for topical application? | Q35963698 | ||
| Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye. | Q36068686 | ||
| Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes | Q36555060 | ||
| Therapeutic options for the management of early neurotrophic keratopathy: a case report and review | Q36603588 | ||
| Topical cyclosporine for treatment of ocular surface disease | Q36632904 | ||
| A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis | Q37306385 | ||
| Topical ophthalmic cyclosporine: pharmacology and clinical uses | Q37473764 | ||
| Topical cyclosporine A as a steroid-sparing agent in steroid-dependent idiopathic ocular myositis with scleritis: a case report and review of the literature | Q37581390 | ||
| Persistent superficial punctate keratitis after resolution of chlamydial follicular conjunctivitis | Q37892911 | ||
| Blindness in Saudi Arabia | Q39307468 | ||
| Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease | Q39344038 | ||
| Management of Thygeson's superficial punctate keratitis. | Q39573494 | ||
| Treatment of Thygeson's superficial punctate keratopathy with soft contact lenses | Q39574806 | ||
| Activated T cells in an animal model of allergic conjunctivitis | Q39696025 | ||
| Cyclosporine: immunology, pharmacology and therapeutic uses | Q39756313 | ||
| Treatment of lichen planus | Q40485561 | ||
| FK506 and cyclosporin, molecular probes for studying intracellular signal transduction | Q40490248 | ||
| Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group | Q40765221 | ||
| Clinical use of cyclosporine in ocular disease. | Q40789392 | ||
| A novel murine model of allergic conjunctivitis | Q40860360 | ||
| Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease | Q40932149 | ||
| A comparative approach to topical cyclosporine therapy | Q41678598 | ||
| Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group | Q41730611 | ||
| Long-term follow-up of patients with atopic keratoconjunctivitis | Q41739625 | ||
| Isolated lichen planus of the conjunctiva | Q42841186 | ||
| Effects of cyclosporin A on human conjunctival fibroblasts | Q43762272 | ||
| Successful topical cyclosporin A in the therapy of progressive vascularising keratitis in keratitis-ichthyosis-deafness (KID) syndrome (Senter syndrome) | Q44048009 | ||
| Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis | Q44177405 | ||
| Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease | Q44206861 | ||
| Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis | Q44548621 | ||
| Topical cyclosporin in the treatment of chronic sarcoidosis of the conjunctiva | Q44578245 | ||
| Antiinflammatory therapy for dry eye. | Q44763839 | ||
| A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis | Q44798762 | ||
| Vernal Keratoconjunctivitis in Nigerians: 109 Consecutive Cases | Q45136784 | ||
| Corneal ulceration and perforation associated with Sjögren's syndrome | Q45186974 | ||
| Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. | Q45245174 | ||
| Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. | Q45418461 | ||
| PCR for varicella zoster virus genome negative in corneal epithelial cells of patients with Thygeson's superficial punctate keratitis | Q45669070 | ||
| Occult thyroid eye disease in patients presenting with dry eye symptoms | Q46124921 | ||
| Effective treatment of ligneous conjunctivitis with topical plasminogen | Q46430743 | ||
| Corticosteroids in corneal graft rejection. Oral versus single pulse therapy | Q46722477 | ||
| Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction | Q46863578 | ||
| Efficacy of topical cyclosporin 0.05% in the treatment of posterior blepharitis | Q46965028 | ||
| Efficacy of topical cyclosporine for the treatment of ocular rosacea | Q48422815 | ||
| Impression cytology and ocular characteristics in ocular rosacea. | Q48969389 | ||
| Immuno-Suppressive Drug Treatment of Keratitis Sicca, including an Example of Lichen Planus of the Conjunctiva. | Q49626139 | ||
| Effective treatment with topical cyclosporin A of a patient with Cogan syndrome. | Q50494030 | ||
| Paediatric ophthalmic problems in Nigeria. | Q50701590 | ||
| Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. | Q50761215 | ||
| Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis. | Q54005119 | ||
| Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. | Q54309870 | ||
| Topical cyclosporin a in the treatment of acute graft rejection: a randomised controlled trial | Q57245035 | ||
| Effectiveness of nedocromil sodium 2% eyedrops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis | Q61685068 | ||
| Prolonged survival of corneal allografts in rabbits treated with cyclosporin A | Q66706219 | ||
| Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy | Q67756849 | ||
| Lichen planus | Q67859010 | ||
| Topical Cyclosporine in Vernal Keratoconjunctivitis | Q67873050 | ||
| Response of reactivated ligneous conjunctivitis to topical cyclosporine | Q67960863 | ||
| Immunopathology of atopic keratoconjunctivitis | Q68018590 | ||
| Severe lichen planus clears with very low-dose cyclosporin | Q68221963 | ||
| Topical cyclosporine therapy for ulcerative keratitis associated with rheumatoid arthritis | Q68771786 | ||
| Ligneous conjunctivitis. A clinicopathologic study of 17 cases | Q69407364 | ||
| Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis | Q69483782 | ||
| Immunopathological study of vernal keratoconjunctivitis | Q69535749 | ||
| Topical treatment of severe corneal ulcers with cyclosporin A | Q69736138 | ||
| [Local treatment of corneal transplants in the human with cyclosporin A] | Q69914539 | ||
| Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis | Q70024643 | ||
| Clinical features of atopic keratoconjunctivitis | Q70125167 | ||
| Ocular Manifestations of Graft-vs-Host Disease | Q70242999 | ||
| The eye in bone marrow transplantation. I. Clinical study | Q70249410 | ||
| Evaluation of topical cromolyn sodium in the treatment of vernal keratoconjunctivitis | Q70406508 | ||
| Immunohistopathologic features and therapy of conjunctival lichen planus | Q70654397 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 352-361 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Ocular Immunology and Inflammation | Q15760486 |
| P1476 | title | Clinical Review: Topical Ophthalmic Use of Cyclosporin A | |
| P478 | volume | 18 |
| Q34253558 | A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. |
| Q56996774 | Advancements in Host-Based Interventions for Influenza Treatment |
| Q89539996 | Aqueous deficiency is a contributor to evaporation-related dry eye disease |
| Q36567529 | Characterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham method |
| Q42514475 | Corneal features in ocular graft-versus-host disease by in vivo confocal microscopy |
| Q92066842 | Corneal graft melting: a systematic review |
| Q39730888 | Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye. |
| Q37242107 | Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells? |
| Q64099037 | Dry eye disease immune responses and topical therapy |
| Q34273384 | Dry eye disease: A review of diagnostic approaches and treatments |
| Q26852044 | Dry eye: an inflammatory ocular disease |
| Q89906676 | Effectiveness of Subconjunctival Cyclosporine in Treatment of Acute Allergic Conjunctivitis in a Rat-Model |
| Q30467905 | Effects of immunosuppressants after penetrating keratoplasty: meta-analysis of randomized controlled trials |
| Q35373820 | Functional and morphological analysis of the subretinal injection of human retinal progenitor cells under Cyclosporin A treatment |
| Q24187740 | Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty |
| Q44049378 | Immunotherapy for corneal inflammatory disorders: stepping up and down the ladder |
| Q52598288 | Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies. |
| Q42464221 | In vivo confocal microscopic characterisation of the cornea in chronic graft-versus-host disease related severe dry eye disease. |
| Q28469505 | Inhibition of Pterygium Fibroblast Migration and Outgrowth by Bevacizumab and Cyclosporine A Involves Down-Regulation of Matrix Metalloproteinases-3 and -13 |
| Q37471561 | Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up |
| Q38778422 | Management of High-risk Corneal Transplantation |
| Q42745061 | Management of vernal keratoconjunctivitis |
| Q90344139 | Management of vernal keratoconjunctivitis in children in Saudi Arabia |
| Q92893248 | Method for selective quantification of immune and inflammatory cells in the cornea using flow cytometry |
| Q26991771 | Novel formulations for antimicrobial peptides |
| Q38040514 | Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. |
| Q36182937 | Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model |
| Q37994335 | Pharmacotherapy of corneal transplantation |
| Q34471317 | Preparation and evaluation of cyclosporin A-containing proliposomes: a comparison of the supercritical antisolvent process with the conventional film method |
| Q47550026 | Social-economic analysis of patients with Sjogren's syndrome dry eye in East China: a cross-sectional study |
| Q92953668 | Solubilization of Cyclosporine in Topical Ophthalmic Formulations: Preformulation Risk Assessment on a New Solid Form |
| Q38904800 | Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation |
| Q36039088 | The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye |
| Q38108573 | The cellular mechanisms of dry eye: from pathogenesis to treatment. |
| Q50480678 | The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren's syndrome. |
| Q38270449 | The role and treatment of inflammation in dry eye disease |
| Q41951650 | Therapeutical Management for Ocular Rosacea |
| Q90116578 | Three Dimensional Culture of Potential Epithelial Progenitor Cells in Human Lacrimal Gland |
| Q42257527 | Topical ophthalmic use of cyclosporin A for Splendore-Hoeppli phenomenon. |
| Q35691929 | Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline |
| Q48315235 | Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops |
| Q26995424 | What is causing the corneal ulcer? Management strategies for unresponsive corneal ulceration |
| Q87450517 | [Immunosuppressives to prevent rejection reactions after allogeneic corneal transplantation] |
Search more.